COST-EFFECTIVENESS OF VOCLOSPORIN IN COMBINATION WITH MYCOPHENOLATE MOFETIL FOR ACTIVE LUPUS NEPHRITIS IN SWEDEN

被引：0
|
作者：
Gittfried, A. [1 ]
Farrington, E. [2 ]
Anell, B. [3 ]
Norman, H. [4 ]
Clamp, D. [2 ]
Blaikie, T. [5 ]
Ektare, V [6 ]
机构：
[1] OPEN Hlth Evidence & Access, Rotterdam, Netherlands
[2] Otsuka Pharmaceut Europe Ltd, Windsor, England
[3] Otsuka Pharma Scandinavia AB, Stockholm, Sweden
[4] Quantify Res AB, Stockholm, Sweden
[5] OPEN Hlth Evidence & Access, London, England
[6] OPEN Hlth Evidence & Access, Mumbai, Maharashtra, India
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE272
引用
收藏
页码：S103 / S104
页数：2
相关论文
共 50 条
  • [1] The cost-effectiveness of mycophenolate mofetil as firstline therapy in active lupus nephritis
    Wilson, E. C. F.
    Jayne, D. R. W.
    Dellow, E.
    Fordham, R. J.
    RHEUMATOLOGY, 2007, 46 (07) : 1096 - 1101
  • [2] The cost-effectiveness of mycophenolate mofetil (MMF) as first-line therapy in active lupus nephritis
    Wilson, E. C.
    Jayne, D. R.
    Dellow, E.
    Fordham, R. J.
    VALUE IN HEALTH, 2007, 10 (03) : A105 - A106
  • [3] EVALUATING THE COST-EFFECTIVENESS OF VOCLOSPORIN IN THE UNITED STATES FOR THE TREATMENT OF LUPUS NEPHRITIS
    Flauto, Ronald
    Lee, Ernie
    Atencio, Victoria
    Birardi, Vanessa
    Kennedy, Lisa
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (04) : S113 - S113
  • [4] The Cost-Effectiveness of Belimumab and Voclosporin for Patients with Lupus Nephritis in the United States
    Mandrik, Olena
    Fotheringham, James
    Ren, Shijie
    Tice, Jeffrey A.
    Chapman, Richard H.
    Stevenson, Matthew D.
    Pearson, Steven D.
    Herron-Smith, Serina
    Agboola, Foluso
    Thokala, Praveen
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (03): : 385 - 394
  • [5] Evaluating the cost-effectiveness of voclosporin for the treatment of lupus nephritis in the United States
    Kennedy, Lisa
    Lee, Ernie
    Flauto, Ronald
    Atencio, Victoria
    Birardi, Vanessa
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (08): : 773 - 781
  • [6] The effectiveness and safety of mycophenolate mofetil in lupus nephritis
    Mazen Elyan
    Stanley Ballou
    Clinical Rheumatology, 2009, 28 : 835 - 840
  • [7] The effectiveness and safety of mycophenolate mofetil in lupus nephritis
    Elyan, Mazen
    Ballou, Stanley
    CLINICAL RHEUMATOLOGY, 2009, 28 (07) : 835 - 840
  • [8] Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis
    Lanata, C. M.
    Mahmood, T.
    Fine, D. M.
    Petri, M.
    LUPUS, 2010, 19 (08) : 935 - 940
  • [9] COMPARATIVE EFFICACY OF VOCLOSPORIN IN COMBINATION WITH MYCOPHENOLATE MOFETIL VERSUS OTHER TREATMENTS IN ACTIVE LUPUS NEPHRITIS: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Lambton, M.
    Farrington, E.
    Clamp, D.
    Badgujar, L.
    Blaikie, T.
    Ektare, V
    VALUE IN HEALTH, 2023, 26 (12) : S47 - S48
  • [10] Mycophenolate mofetil for lupus nephritis
    McCune, WJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (21): : 2282 - 2284
12345